🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

¡Gracias a todos por acompañarnos hoy en la sesión sobre 'Tratamiento de la Esclerosis Múltiple Pediátrica'! 🙌 Un agradecimiento especial a los ponentes por compartir su conocimiento y, junto a nuestros partners, hacer posible este programa. 🧠💡 ¡En 2025 seguimos con más

Actualiztació en Neurologia Vall d'Hebron. Very interesting ongping projects in the different areas of Neurology, recognition of young neurologists/neuroscientists, and important changes gping forward. Xavier Montalban Patricia Pozo-Rosich Estevo_Santamarina Rene Carvajal Junco and many more!

The benefits of early initiation of disease-modifying therapy in MS are well-established, but when & how to de-escalate treatment remains unclear. Androdias et al. summarise findings from an ECTRIMS workshop on this topic and propose practical guidelines. tinyurl.com/mr2rvxcu

📰Entrevista amb el Dr. Xavier Montalban per VÍCTOR AMELA de La Vanguardia, publicada avui 21/1/25 a La Contra, sobre els grans avenços aconseguits en #esclerosimultiple, molts gràcies a la tasca de quasi 30 anys en assistència i recerca de l'equip Cemcat Vall d'Hebron Vall d'Hebron Institut de Recerca

The impact of ageingt on long-term outcomes in MS. neurology.org/doi/10.1212/WN…

Diagnosing #MultipleSclerosis requires ruling out better explanations, and the most common alternative diagnoses are MOGAD, functional disorders and vascular disease. From the Barcelona CIS cohort Andreu Vilaseca Georgina Arrambide Cemcat Vall d'Hebron ▶️ journals.sagepub.com/doi/abs/10.117…

In our Consensus Statement in Nature Reviews Neurology, we provide guidance and recommendations for the use of autologous haematopoietic stem cell transplantation in MS and NMOSD. Nat Rev Neurology nature.com/articles/s4158…

Vaccination in #MultipleSclerosis: Tackling challenges and paving the way for effective immunization. Review from Rene Carvajal Junco Mar Tintore Cemcat Vall d'Hebron ▶️ journals.sagepub.com/doi/abs/10.117…

💉Vacunación en #EsclerosisMúltiple: Afrontar los retos y allanar el camino para una inmunización eficaz. Mas información 🖇️journals.sagepub.com/doi/abs/10.117…

It is with great pleasure that we present the Barcelona BRS model for patients with a first demyelinating attack: a ready-to-use risk assessment tool Mar Tintore Xavier Montalban Cemcat Vall d'Hebron Institut de Recerca THANKS!!

New study presents the Barcelona-BRS model—an adaptable, ready-to-use #MS tool to aid in early risk stratification and #PersonalisedMedicine after a first demyelinating attack. Read the full Article 👇 Carmen Tur Mar Tintore Xavier Montalban thelancet.com/journals/lanep…

#VallHebron presenta el primer model capaç de predir l’evolució a llarg termini de l’#esclerosimúltiple des del primer brot. Una eina clínica flexible i generalitzable, que serà clau a l’hora d’escollir el tractament més eficaç en cada cas. 👇vallhebron.com/actualitat/not…

Orgullosa d'explicar l'eina Barcelona-BRS per predir el pronòstic de les persones amb un primer brot d'esclerosi múltiple. Mil gràcies Xavier Montalban Mar Tintore Cemcat Vall d'Hebron Institut de Recerca & pacients amb EM

🥼 Nos alegra compartir que la Dra. Mar Tintore asume la presidencia del Comité Médico Asesor de Esclerosis Múltiple España. La neuróloga Mar Tintoré es Jefa Asistencial del Cemcat del Servicio de #Neurología-#Neuroinmunología del 🏥Vall d'Hebron  Su liderazgo refuerza el

Pansieri et al. argue that bureaucracy is suffocating research, as an ever increasing administrative burden consumes researchers’ time and diverts focus from discovery to compliance. tinyurl.com/muv2nr52

🔊 Listen to Andreu Vilaseca Angela Vidal-Jordana Xavier Montalban Cemcat on how we could accurately diagnose a subclinical period of #MultipleSclerosis. 📰 And read the full manuscript ▶️ journals.sagepub.com/doi/full/10.11…

Very pleased to share our latest paper! Deep learning to predict progression independent of relapse activity at a first demyelinating event academic.oup.com/braincomms/art… Thanks so much Vall d'Hebron Institut de Recerca Cemcat Mar Tintore Xavier Montalban Alex Rovira D.Pareto X.LLadó LL.Coll Instituto de Salud Carlos III (ISCIII)